Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
BCPC vs LIN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
BCPC vs LIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $5.17B | $232.56B |
| Revenue (TTM) | $1.06B | $34.66B |
| Net Income (TTM) | $158M | $7.13B |
| Gross Margin | 36.3% | 46.0% |
| Operating Margin | 21.0% | 28.8% |
| Forward P/E | 31.2x | 28.1x |
| Total Debt | $192M | $26.99B |
| Cash & Equiv. | $75M | $5.06B |
BCPC vs LIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Balchem Corporation (BCPC) | 100 | 160.3 | +60.3% |
| Linde plc (LIN) | 100 | 248.0 | +148.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BCPC vs LIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BCPC is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- Lower volatility, beta 0.33, Low D/E 15.3%, current ratio 2.07x
- 8.8% revenue growth vs LIN's 3.0%
LIN carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 6 yrs, beta 0.24, yield 1.2%
- 376.9% 10Y total return vs BCPC's 162.8%
- PEG 1.11 vs BCPC's 2.44
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.8% revenue growth vs LIN's 3.0% | |
| Value | Lower P/E (28.1x vs 31.2x), PEG 1.11 vs 2.44 | |
| Quality / Margins | 20.6% margin vs BCPC's 15.0% | |
| Stability / Safety | Beta 0.24 vs BCPC's 0.33 | |
| Dividends | 0.5% yield, 11-year raise streak, vs LIN's 1.2% | |
| Momentum (1Y) | +13.6% vs BCPC's -0.8% | |
| Efficiency (ROA) | 9.4% ROA vs LIN's 8.3%, ROIC 12.2% vs 11.3% |
BCPC vs LIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BCPC vs LIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 32.8x BCPC's $1.1B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to BCPC's 15.0%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.1B | $34.7B |
| EBITDAEarnings before interest/tax | $267M | $12.1B |
| Net IncomeAfter-tax profit | $158M | $7.1B |
| Free Cash FlowCash after capex | $182M | $5.1B |
| Gross MarginGross profit ÷ Revenue | +36.3% | +46.0% |
| Operating MarginEBIT ÷ Revenue | +21.0% | +28.8% |
| Net MarginNet income ÷ Revenue | +15.0% | +20.6% |
| FCF MarginFCF ÷ Revenue | +17.2% | +14.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.1% | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +10.6% | +13.4% |
Valuation Metrics
BCPC leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 34.0x trailing earnings, BCPC trades at a 1% valuation discount to LIN's 34.4x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.36x vs BCPC's 2.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $5.2B | $232.6B |
| Enterprise ValueMkt cap + debt − cash | $5.3B | $254.5B |
| Trailing P/EPrice ÷ TTM EPS | 33.97x | 34.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 31.23x | 28.12x |
| PEG RatioP/E ÷ EPS growth rate | 2.65x | 1.36x |
| EV / EBITDAEnterprise value multiple | 20.06x | 20.04x |
| Price / SalesMarket cap ÷ Revenue | 4.98x | 6.84x |
| Price / BookPrice ÷ Book value/share | 4.18x | 5.92x |
| Price / FCFMarket cap ÷ FCF | 29.86x | 45.70x |
Profitability & Efficiency
BCPC leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $12 for BCPC. BCPC carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIN's 0.68x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs LIN's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +12.4% | +17.8% |
| ROA (TTM)Return on assets | +9.4% | +8.3% |
| ROICReturn on invested capital | +12.2% | +11.3% |
| ROCEReturn on capital employed | +14.8% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 6 |
| Debt / EquityFinancial leverage | 0.15x | 0.68x |
| Net DebtTotal debt minus cash | $117M | $21.9B |
| Cash & Equiv.Liquid assets | $75M | $5.1B |
| Total DebtShort + long-term debt | $192M | $27.0B |
| Interest CoverageEBIT ÷ Interest expense | 15.23x | 34.52x |
Total Returns (Dividends Reinvested)
LIN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $17,813 today (with dividends reinvested), compared to $12,441 for BCPC. Over the past 12 months, LIN leads with a +13.6% total return vs BCPC's -0.8%. The 3-year compound annual growth rate (CAGR) favors LIN at 12.4% vs BCPC's 8.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +4.8% | +17.3% |
| 1-Year ReturnPast 12 months | -0.8% | +13.6% |
| 3-Year ReturnCumulative with dividends | +28.0% | +41.9% |
| 5-Year ReturnCumulative with dividends | +24.4% | +78.1% |
| 10-Year ReturnCumulative with dividends | +162.8% | +376.9% |
| CAGR (3Y)Annualised 3-year return | +8.6% | +12.4% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than BCPC's 0.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.3% from its 52-week high vs BCPC's 87.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.33x | 0.24x |
| 52-Week HighHighest price in past year | $183.90 | $521.28 |
| 52-Week LowLowest price in past year | $139.17 | $387.78 |
| % of 52W HighCurrent price vs 52-week peak | +87.8% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 32.3 | 50.6 |
| Avg Volume (50D)Average daily shares traded | 189K | 2.3M |
Analyst Outlook
Evenly matched — BCPC and LIN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BCPC as "Buy" and LIN as "Buy". Consensus price targets imply 7.5% upside for LIN (target: $540) vs 0.4% for BCPC (target: $162). For income investors, LIN offers the higher dividend yield at 1.20% vs BCPC's 0.54%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $162.00 | $539.71 |
| # AnalystsCovering analysts | 10 | 28 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +1.2% |
| Dividend StreakConsecutive years of raises | 11 | 6 |
| Dividend / ShareAnnual DPS | $0.87 | $6.00 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +2.0% |
LIN leads in 3 of 6 categories (Income & Cash Flow, Total Returns). BCPC leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
BCPC vs LIN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BCPC or LIN a better buy right now?
For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.
8% revenue growth year-over-year, versus 3. 0% for Linde plc (LIN). Balchem Corporation (BCPC) offers the better valuation at 34. 0x trailing P/E (31. 2x forward), making it the more compelling value choice. Analysts rate Balchem Corporation (BCPC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BCPC or LIN?
On trailing P/E, Balchem Corporation (BCPC) is the cheapest at 34.
0x versus Linde plc at 34. 4x. On forward P/E, Linde plc is actually cheaper at 28. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 11x versus Balchem Corporation's 2. 44x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BCPC or LIN?
Over the past 5 years, Linde plc (LIN) delivered a total return of +78.
1%, compared to +24. 4% for Balchem Corporation (BCPC). Over 10 years, the gap is even starker: LIN returned +376. 9% versus BCPC's +162. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BCPC or LIN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Balchem Corporation's 0. 33β — meaning BCPC is approximately 37% more volatile than LIN relative to the S&P 500. On balance sheet safety, Balchem Corporation (BCPC) carries a lower debt/equity ratio of 15% versus 68% for Linde plc — giving it more financial flexibility in a downturn.
05Which is growing faster — BCPC or LIN?
By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.
8% versus 3. 0% for Linde plc (LIN). On earnings-per-share growth, the picture is similar: Balchem Corporation grew EPS 20. 9% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BCPC or LIN?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus 14. 9% for Balchem Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 21. 1% for BCPC. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BCPC or LIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 11x versus Balchem Corporation's 2. 44x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Linde plc (LIN) trades at 28. 1x forward P/E versus 31. 2x for Balchem Corporation — 3. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIN: 7. 5% to $539. 71.
08Which pays a better dividend — BCPC or LIN?
All stocks in this comparison pay dividends.
Linde plc (LIN) offers the highest yield at 1. 2%, versus 0. 5% for Balchem Corporation (BCPC).
09Is BCPC or LIN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, BCPC: +162. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BCPC and LIN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.